Methylenetetrahydrofolate reductase polymorphisms in methotrexate treatment of rheumatoid arthritis patients. Review of the literature and personal experience

Methotrexate is still a mainstay of rheumatoid arthritis treatment, but a significant variability in drug response is observed among patients. It has been proposed that C677T and A1298C polymorphisms of methylenetetrahydrofolate reductase (MTHFR), an enzyme involved in the folate pathway, could be r...

Full description

Saved in:
Bibliographic Details
Main Authors: R. Cattaneo (Author), M. Ferrari (Author), S. Archetti (Author), L. Andreoli (Author), M. Taraborelli (Author), A. Tincani (Author)
Format: Book
Published: PAGEPress Publications, 2011-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_e718bc4aeebd4e2bbbc1d156a6345324
042 |a dc 
100 1 0 |a R. Cattaneo  |e author 
700 1 0 |a M. Ferrari  |e author 
700 1 0 |a S. Archetti  |e author 
700 1 0 |a L. Andreoli  |e author 
700 1 0 |a M. Taraborelli  |e author 
700 1 0 |a A. Tincani  |e author 
245 0 0 |a Methylenetetrahydrofolate reductase polymorphisms in methotrexate treatment of rheumatoid arthritis patients. Review of the literature and personal experience 
260 |b PAGEPress Publications,   |c 2011-06-01T00:00:00Z. 
500 |a 10.4081/reumatismo.2009.98 
500 |a 0048-7449 
500 |a 2240-2683 
520 |a Methotrexate is still a mainstay of rheumatoid arthritis treatment, but a significant variability in drug response is observed among patients. It has been proposed that C677T and A1298C polymorphisms of methylenetetrahydrofolate reductase (MTHFR), an enzyme involved in the folate pathway, could be related to its efficacy and toxicity. Many studies have investigated the predictive value of such polymorphisms for Methotrexate outcome, though with discordant results. Our experience on 79 patients did not find any significant association between genotype and drug response and the review of the literature did not provide sufficient evidences to support the use of MTHFR genetic screening in clinical practice. 
546 |a EN 
546 |a IT 
690 |a Medicine 
690 |a R 
690 |a Internal medicine 
690 |a RC31-1245 
655 7 |a article  |2 local 
786 0 |n Reumatismo, Vol 61, Iss 2, Pp 98-106 (2011) 
787 0 |n http://www.reumatismo.org/index.php/reuma/article/view/428 
787 0 |n https://doaj.org/toc/0048-7449 
787 0 |n https://doaj.org/toc/2240-2683 
856 4 1 |u https://doaj.org/article/e718bc4aeebd4e2bbbc1d156a6345324  |z Connect to this object online.